Abstract
The adenosine receptors associated with the adipocyte and brain cortex adenylate cyclase are typical of those neurotransmitter receptors that inhibit the enzyme’s activity in numerous tissues (1). This receptor regulates enzyme activity through a GTP regulatory protein complex (Ni) that is distinct from that which mediates stimulation of the enzyme (Ns) (2–7). The GTP regulatory complex modulates enzyme activity via a GTP hydrolytic cycle involving heterotropic interactions with the receptor and catalytic unit (8–13). Considerable progress has recently been made on characterizing the two types of GTP regulatory complex. Both appear to be comprised of at least three subunits, one of which is unique and two that are common to both complexes. The unique subunit associated with N. can be ADP-ribosylated by islet-activating protein (IAP) a toxin elicited by Bordetella pertussis (7,14,15). At present, the most direct evidence that the IAP substrate is a functional component of Ni mediating hormone inhibition is the demonstration of attenuation of hormonal inhibition by IAP and the reversal of this attenuation by the addition of exogenous (non-treated) IAP substrate (14–16). Such evidence clearly supports a role for the IAP substrate in an Ni complex, although it does not exclude the possibility that other subunits might be required for the promotion of hormonal inhibition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Londos, C., Cooper, D.M.F. and Rodbell, M. (1981). Adv. Cyclic. Nucleotide Res. 14, 163–171.
Jakobs, K.H. (1979). Mol. Cell. Endocrinol. 16, 147–156.
Rodbell, M. (1980). Nature 284, 17–22.
Limbird, L.E. (1981). Biochem. J. 195, 1–13.
Cooper, D.M.F. (1982). FEBS Lett. 138, 157–163.
Hildebrandt, J.D., Sekura, R.D., Codina, J., Iyengar, R., Manclark, C.R. and Bimbaumer, L. (1983). Nature 302:706–709.
Gilman, A.G. (1984). Cell 36,577–579.
Cassel, D. and Selinger, Z. (1976). Biochem. Biophys. Acta 452, 538–551.
Ross, E.M. and Gilman, A.G. (1980). Ann. Rev. Biochem. 49, 533–564.
Aktories, K. and Jakobs, K.H. (1981). FEBS Lett. 130, 235–238.
Koski, G. and Klee, W.A. (1981). Proc. Natl. Acad. Sci. USA 78 4185–4189.
Aktories, K., Schultz, G. and Jakobs, K.H. (1982). Mol. Pharmacol. 21, 336–342.
Michel, T. and Lefkowitz, R.J. (1982). J. Biol. Chem. 257, 13557–13563.
Katada, T. and Ui, M. (1982). Proc. Nat! Acad. Sci. USA 79, 3129–3133.
Katada, T. and Ui, M. (1982). J. Biol. Chem. 257, 7210–7216.
Katada, T., Bokoch, G.M., Northup, J.K., Ui, M. and Gilman, A.G. (1984). J. Biol. Chem. 259, 3568–3577.
Brandt, D.R., Asano, T., Pedersen, S.E. and Ross, E.M. (1983). Biochemistry 22, 4357–4362.
Caron, M.G., Cerione, R.A., Benovic, J.L., Strulovici, B., Staniszewski, C., Lefkowitz, R.J., Codina-Salada, J. and Bimbaumer, L., (in press) Adv. Cyclic, Nucleotide Res.
Tsai, B.S. and Lefkowitz, R.J. (1979). Mol. Pharmacol. 61–68.
U’Prichard, D.C. and Snyder, S.H. (1980). J. Neurochem. 34, 385–394.
Yeung, S.-M.H. and Green R.D. (1983). J. Biol. Chem. 258, 2334–2339.
Codina,.1, Hildebrandt, J., Iyengar, R., Bimbaumer, L., Sekura, R.D. and Manclark, C.R. (1983). Proc. Natl. Acad. Sci. USA 80, 4276–4280.
Cooper, D.M.F., Schlegel, W., Lin, M.C. and Rodbell, M. (1979). J. Biol. Chem. 254, 8927–8930.
Jakobs, K.H. and Aktories, K. (1981). Biochem. Biophys. Acta. 676, 51–58.
Hoffman, B.B., Yim, S., Tsai, B.S. and Lefkowitz, R.J. (1981). Biochem. Biophys. Res. Commun. 100,724–731.
Bockaert, J., Cantau, B. and Sebben-Perez, M. (in press) Mol. Pharm acol.
Schramm, M. and Naim, E. (1970). J. Biol. Chem. 245, 3225–3231.
Schramm, M. (1976). J. Cyc. Nuc. Res. 2 347–358.
Yeung, S-M. H., Fossom, L.H., Gill, D.L. and Cooper, D.M.F. submitted.
Trost, T. and Schwabe, U. (1981). Mol. Pharrnacot, 19, 228–235.
MlI1son, P.J. and Rodbard, D. (1980). Anal. Biochem. 107, 220–239.
Neer, E.J. (1976). J. BioI. Chern. 249, 6527–6532.
Kilpatrick, B.F. and Caron, M.G. (1983). J. BioI. Chern. 258, 13528–13534.
Lew, J.Y. and Goldstein, M. (1984). J. Neurochem. 42, 1298–1305.
Harmon, J. T., Kempner, E.S. and Kahn, C.R. (1981). J. Biol, Chern. 256, 7719–7722.
Kincaid, R.L., Kempner, E.S., Manganiello, V.C., Osbourne, J.C. and Vaughan, M. (1981). J. arer, Chern. 256, 11351–11355.
Avissars, S., Amitai, G. and Sokolovsky, M. (1983). Proc. Natl, Acad. Sci. USA 80, 156–159.
Chang, HW. and Bock, E. (1977) Biochemistry 16, 4513–4520
Venter, C. (1984). In: Neurotransmitter Receptors: Mechanisms of Action and Regulation. S. Kito, K. Kuriyama, HI. Yamamura and R.W. Olsen (eds) Plenum Press.
Editor information
Editors and Affiliations
Copyright information
© 1985 The Contributors
About this chapter
Cite this chapter
Yeung, SM.H., Frame, L.T., Venter, J.C., Cooper, D.M.F. (1985). Magnesium Ions Exert a Central Role in Integrating Adenosine Receptor Occupancy with the Inhibition of Adenylate Cyclase. In: Stone, T.W. (eds) Purines. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07564-5_21
Download citation
DOI: https://doi.org/10.1007/978-1-349-07564-5_21
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07566-9
Online ISBN: 978-1-349-07564-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)